ACMJ
Anatolian Current Medical Journal

Anatolian Current Medical Journal (ACMJ) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

eISSN: 2718-0115
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Attention deficit hyperactivity disorder in the diabetic population: relationship with metabolic syndrome and atherogenic index of plasma
Abstract
Aims: The objective of the current study is to investigate the prevalence of Attention Deficit/Hyperactivity Disorder (ADHD) among individuals diagnosed with diabetes mellitus (DM). Additionally, this study aims to evaluate the potential association between ADHD and metabolic syndrome (MetS), atherogenic index of plasma (AIP), and other lipid parameters, considering the different types of DM.
Methods: The study comprised 213 adult patients diagnosed with diabetes mellitus, consisting of 120 females and 93 males. Participants completed the Adult Attention Deficit Hyperactivity Disorder Self-Report Scale (ASRS) as a screening tool for symptoms. The study assessed many physiological indicators, including body mass index, waist circumference, blood pressure, glucose levels, cholesterol levels, high-density lipoprotein levels, low-density lipoprotein levels, triglyceride levels, uric acid levels, and glycated hemoglobin levels.
Results: The study yielded a prevalence rate of 10.7% for ADHD among diabetes individuals. The prevalence of ADHD was found to be more common in individuals diagnosed with type 1 diabetes mellitus (T1DM) compared to those with type 2 diabetes mellitus (T2DM), with rates of 15.4% and 9.8% respectively. The study revealed that individuals diagnosed with T2DM who also had MetS, organ involvement, concurrent disorders, and stress-related eating had significantly higher scores on the ASRS/T scale. There was a correlation observed between the ASRS-HI and AIP levels in individuals diagnosed with T2DM. The statistical analysis revealed that ADHD-HI and T scores significantly influenced the severity of MetS. A progressive increase in ASRS/T and ASRS/I scores was observed with the duration of DM.
Conclusion: In conclusion, by recognizing and treating accompanying neuropsychiatric conditions such as ADHD symptoms in diabetic patients, individuals may exhibit improved adherence to lifestyle modifications and antidiabetic therapies. This approach potentially reduces the risks of acute and chronic complications, including cardiovascular risk, through the enhanced management of DM.

Keywords : Diabetes mellitus, attention deficit hyperactivity disorder, metabolic syndrome, atherogenic index of plasma

Download Article


1. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetesprevalence estimates for 2019 and projections for 2030 and 2045:results from the International Diabetes Federation DiabetesAtlas. Diabetes Res Clin Pract. 2019;157:107843.
2. Landau Z, Pinhas-Hamiel O. Attention deficit/hyperactivity,the metabolic syndrome, and type 2 diabetes. Curr Diab Rep.2019;19(8):46.
3. Matthews M, Nigg JT, Fair DA. Attention deficit hyperactivitydisorder. Curr Top Behav Neurosci. 2014;16:235-266.
4. Faraone SV, Doyle AE. Genetic influences on attention deficithyperactivity disorder. Curr Psychiatry Rep. 2000;2(2):143-146.
5. Florez JC, Hirschhorn J, Altshuler D. The inherited basis ofdiabetes mellitus: implications for the genetic analysis of complextraits. Annu Rev Genomics Hum Genet. 2003;4(1):257-291.
6. Song P, Zha M, Yang Q, Zhang Y, Li X, Rudan I. The prevalence ofadult attention-deficit hyperactivity disorder: a global systematicreview and meta-analysis. J Glob Health. 2021;11:04009. doi:10.7189/jogh.11.04009.
7. Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalenceand correlates of adult attention-deficit hyperactivity disorder. BrJ Psychiatry. 2007;190(5):402-409.
8. Tannock R. Rethinking ADHD and LD in DSM-5: proposedchanges in diagnostic criteria. J Learn Disabil. 2013;46(1):5-25.
9. Arnsten AF. Fundamentals of attention-deficit/hyperactivitydisorder: circuits and pathways. J Clin Psychiatry. 2006;67(Suppl8):7-12.
10. Robbins TW. Chemistry of the mind: neurochemical modulationof prefrontal cortical function. J Comp Neurol. 2005;493(1):140-146.
11. Pérez-Taboada I, Alberquilla S, Martín ED, et al. Diabetescauses dysfunctional dopamine neurotransmission favoringnigrostriatal degeneration in mice. Mov Disord. 2020;35(9):1636-1648.
12. Hansen F, Pandolfo P, Galland F, et al. Methylglyoxal can mediatebehavioral and neurochemical alterations in rat brains. PhysiolBehav. 2016;164(Pt A):93-101.
13. Akhter F, Chen D, Akhter A, et al. High dietary advancedglycation end products impair mitochondrial and cognitivefunction. J Alzheimers Dis. 2020;76(1):165-178.
14. Pignalosa FC, Desiderio A, Mirra P, et al. Diabetes andcognitive impairment: a role for glucotoxicity and dopaminergicdysfunction. Int J Mol Sci. 2021;22(22):12366.
15. Barzilay JI, Lovato JF, Murray AM, et al. Albuminuria andcognitive decline in people with diabetes and normal renalfunction. Clin J Am Soc Nephrol. 2013;8(11):1907-1914.
16. Xu Y, Bao L, Liu C. The relationship between blood lipid andattention-deficit/hyperactivity disorder (ADHD) in an obesepopulation of Chinese children: an obesity-stratified cross-sectional study. Int J Gen Med. 2021;14:10503-10509.
17. Chen MH, Pan TL, Hsu JW, et al. Risk of type 2 diabetes inadolescents and young adults with attention-deficit/hyperactivitydisorder: a nationwide longitudinal study. J Clin Psychiatry.2018;79(3):17m11607.
18. Kapellen TM, Reimann R, Kiess W, Kostev K. Prevalence ofmedically treated children with ADHD and type 1 diabetes inGermany - analysis of two representative databases. J PediatrEndocrinol Metab. 2016;29(11):1293-1297.
19. Butwicka A, Frisén L, Almqvist C, Zethelius B, Lichtenstein P.Risks of psychiatric disorders and suicide attempts in childrenand adolescents with type 1 diabetes: a population-basedcohort study [published correction appears in Diabetes Care.2016;39(3):495]. Diabetes Care. 2015;38(3):453-459.
20. Hilgard D, Konrad K, Meusers M, et al. Comorbidity of attentiondeficit hyperactivity disorder and type 1 diabetes in childrenand adolescents: analysis based on the multicentre DPVregistry. Pediatr Diabetes. 2017;18(8):706-713.
21. Hsu JL, Chen YL, Leu JG, et al. Microstructural white matterabnormalities in type 2 diabetes mellitus: a diffusion tensorimaging study. Neuroimage. 2012;59(2):1098-1105.
22. Novak V, Last D, Alsop DC, et al. Cerebral blood flow velocityand periventricular white matter hyperintensities in type 2diabetes. Diabetes Care. 2006;29(7):1529-1534.
23. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis andmanagement of the metabolic syndrome: an American HeartAssociation/National Heart, Lung, and Blood Institute ScientificStatement. Circulation. 2005;112(17):e297.
24. Doğan S, Öncü B, Varol Saraçoğlu G, Küçükgöncü S. Erişkindikkat eksikliği hiperaktivite bozukluğu kendi bildirim ölçeği(ASRS-v1. 1): Türkçe formunun geçerlilik ve güvenilirliği.Anadolu Psikiyatri Derg. 2009;10(2):77-87.
25. Pazvantoğlu O, Akbaş S, Sarısoy G, Baykal S, Zabun Korkmaz I,Bekiroğlu K. DEHB tanılı çocukların ebeveynlerinde DEHB ileilişkili bazı sorunlu yaşam olayları. Düşünen Adam. 2014;27:61-68.
26. Chen Q, Hartman CA, Haavik J, et al. Common psychiatric andmetabolic comorbidity of adult attention-deficit/hyperactivitydisorder: a population-based cross-sectional study. PLoS One.2018;13(9):e0204516.
27. Xu G, Liu B, Yang W, Snetselaar LG, Jing J. Association ofattention-deficit/hyperactivity disorder with diabetes mellitus inUS adults. J Diabetes. 2021;13(4):299-306.
28. Xie XN, Lei X, Xiao CY, Li YM, Lei XY. Association betweentype 1 diabetes and neurodevelopmental disorders in childrenand adolescents: a systematic review and meta-analysis. FrontPsychiatry. 2022;13:982696.
29. Vinker-Shuster M, Eldor R, Green I, Golan-Cohen A, Manor I,Merzon E. Glycemic control and diabetes related complicationsin adults with type 1 diabetes mellitus and ADHD. J Atten Disord.2022;26(9):1235-1244.
30. Li L, Chang Z, Sun J, et al. Attention-deficit/hyperactivitydisorder as a risk factor for cardiovascular diseases: a nationwidepopulation-based cohort study. World Psychiatry. 2022;21(3):452-459.
31. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors:the Framingham study. Circulation. 1979;59(1):8-13.
32. Ranasinghe P, Mathangasinghe Y, Jayawardena R, Hills AP, MisraA. Prevalence and trends of metabolic syndrome among adults inthe asia-pacific region: a systematic review. BMC Public Health.2017;17(1):101.
33. Tan MC, Ng OC, Wong TW, Joseph A, Chan Y, Hejar A.Prevalence of metabolic syndrome in type 2 diabetic patients:a comparative study using WHO, NCEP ATP III, IDF andharmonized definitions. Health. 2013;5(10):1689-1696.
34. Pambianco G, Costacou T, Orchard TJ. The prediction of majoroutcomes of type 1 diabetes: a 12-year prospective evaluationof three separate definitions of the metabolic syndrome andtheir components and estimated glucose disposal rate: thePittsburgh Epidemiology of Diabetes Complications Studyexperience. Diabetes Care. 2007;30(5):1248-1254.
Article available in :
Volume 6, Issue 1, 2024
Page : 65-72
https://doi.org/10.38053/acmj.1377140
Article Information
Received : 19 Eki 2023
Accepted : 15 Ara 2023
Published : 15 Oca 2024
Corresponding Author :

Serpil Çiftel: Department of Endocrinology and Metabolism Diseases, Faculty of Medicine, University of Health Sciences, Erzurum, Turkiye

[email protected]
Citation : Çiftel S, Gürbüzer N. Attention deficit hyperactivity disorder in the diabetic population: relationship with metabolic syndrome and atherogenic index of plasma. Anatolian Curr Med J. 2024;6(1):65-72.

Read: 35
Cited: 0
Download : 49
_Footer